Literature DB >> 17855614

Decreased central mu-opioid receptor availability in fibromyalgia.

Richard E Harris1, Daniel J Clauw, David J Scott, Samuel A McLean, Richard H Gracely, Jon-Kar Zubieta.   

Abstract

The underlying neurophysiology of acute pain is fairly well characterized, whereas the central mechanisms operative in chronic pain states are less well understood. Fibromyalgia (FM), a common chronic pain condition characterized by widespread pain, is thought to originate largely from altered central neurotransmission. We compare a sample of 17 FM patients and 17 age- and sex-matched healthy controls, using mu-opioid receptor (MOR) positron emission tomography. We demonstrate that FM patients display reduced MOR binding potential (BP) within several regions known to play a role in pain modulation, including the nucleus accumbens, the amygdala, and the dorsal cingulate. MOR BP in the accumbens of FM patients was negatively correlated with affective pain ratings. Moreover, MOR BP throughout the cingulate and the striatum was also negatively correlated with the relative amount of affective pain (McGill, affective score/sensory score) within these patients. These findings indicate altered endogenous opioid analgesic activity in FM and suggest a possible reason for why exogenous opiates appear to have reduced efficacy in this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855614      PMCID: PMC6672650          DOI: 10.1523/JNEUROSCI.2849-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  162 in total

Review 1.  Central pain mechanisms in chronic pain states--maybe it is all in their head.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-04       Impact factor: 4.098

2.  Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors:  Irene Tracey
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

3.  Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity.

Authors:  Vitaly Napadow; Lauren LaCount; Kyungmo Park; Sawsan As-Sanie; Daniel J Clauw; Richard E Harris
Journal:  Arthritis Rheum       Date:  2010-08

4.  Prevalence of the fibromyalgia phenotype in patients with spine pain presenting to a tertiary care pain clinic and the potential treatment implications.

Authors:  Chad M Brummett; Jenna Goesling; Alex Tsodikov; Taha S Meraj; Ronald A Wasserman; Daniel J Clauw; Afton L Hassett
Journal:  Arthritis Rheum       Date:  2013-12

5.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 6.  [Cytokine regulation and pain. Results of experimental and clinical research].

Authors:  N Uçeyler; C Sommer
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 7.  Review of overlap between thermoregulation and pain modulation in fibromyalgia.

Authors:  Alice A Larson; José V Pardo; Jeffrey D Pasley
Journal:  Clin J Pain       Date:  2014-06       Impact factor: 3.442

8.  Striatal hypofunction as a neural correlate of mood alterations in chronic pain patients.

Authors:  Minhae Kim; Ishtiaq Mawla; Daniel S Albrecht; Roee Admon; Angel Torrado-Carvajal; Courtney Bergan; Ekaterina Protsenko; Poornima Kumar; Robert R Edwards; Atreyi Saha; Vitaly Napadow; Diego A Pizzagalli; Marco L Loggia
Journal:  Neuroimage       Date:  2020-02-15       Impact factor: 6.556

Review 9.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

Review 10.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.